Astrazeneca Plc (AZN.LN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-1999 | 12-1998 | 12-1997 | 12-1996 | 12-1995 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 428,789 | 341,937 | 500,893 | 443,539 | 251,870 |
| Marketable Securities | 2,857,595 | 273,882 | 704,225 | 1,226,153 | 971,939 |
| Inventories | 2,154,940 | 1,324,591 | 1,203,465 | 1,166,216 | 1,314,976 |
| Other current assets | 4,242,913 | 2,390,240 | 2,172,188 | 2,251,944 | 2,217,381 |
| TOTAL | $9,909,127 | $4,463,441 | $4,721,285 | $5,197,452 | $4,864,330 |
| Non-Current Assets | |||||
| PPE Net | 5,978,061 | 3,636,816 | 3,225,220 | 3,120,184 | 2,915,817 |
| Intangibles | 3,734,163 | 637,397 | 133,902 | 42,813 | 27,814 |
| Other Non-Current Assets | 184,908 | 242,344 | 201,680 | 202,076 | 61,809 |
| TOTAL | $9,897,132 | $4,516,557 | $3,560,801 | $3,365,072 | $3,005,439 |
| Total Assets | $19,806,259 | $8,979,998 | $8,282,087 | $8,562,524 | $7,869,769 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 378,815 | 278,861 | 309,132 | 397,301 | 418,753 |
| Accounts payable and accrued liabilities | 1,613,207 | 976,015 | 874,496 | 820,290 | 822,053 |
| TOTAL | $7,015,548 | $3,324,757 | $3,079,746 | $3,202,384 | $3,127,511 |
| Non-Current Liabilities | |||||
| Long Term Debt | 739,635 | 763,549 | 862,924 | 845,977 | 849,867 |
| Other Non-Current Liabilities | 1,674,177 | 612,499 | 662,898 | 674,727 | 695,346 |
| TOTAL | $2,453,792 | $1,429,164 | $1,578,721 | $1,698,805 | $1,705,915 |
| Total Liabilities | $9,469,340 | $4,753,921 | $4,658,467 | $4,901,188 | $4,833,426 |
| Shareholders' Equity | |||||
| Common Shares | 443,782 | 395,054 | 391,787 | 405,864 | 366,215 |
| Retained earnings | 8,533,807 | 3,069,134 | 2,449,911 | 2,068,706 | 1,648,742 |
| Other shareholders' equity | 1,117,450 | 655,656 | 689,347 | 993,253 | 849,867 |
| TOTAL | $10,296,939 | $4,172,960 | $3,570,720 | $3,483,235 | $2,875,641 |
| Total Liabilities And Equity | $19,766,279 | $8,926,882 | $8,229,187 | $8,384,423 | $7,709,067 |